NCT02655380View on ClinicalTrials.gov

Remifentanil Requirement for Acceptable Intubating Condition

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

April 16, 2018

Study Completion Date

April 16, 2018

Conditions
Intubating Condition
Interventions
DRUG

Ketamine 1

Anesthesia induction is performed with 1 mg ketamine.

DRUG

Ketamine 2

Anesthesia induction is performed with 2 mg ketamine.

DRUG

Remifentanil

After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.

Trial Locations (1)

16499

Ajou universitiy school of medicine, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT02655380 - Remifentanil Requirement for Acceptable Intubating Condition | Biotech Hunter | Biotech Hunter